Menu
James Dunn

James Dunn

James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian. His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007, and a third edition was published in April 2011. There have also been two editions of the mini-version, Getting Started in Shares for Dummies. James is also a regular finance commentator on Australian radio and television: he gives a daily finance report on Radio 3AW in Melbourne and is a weekly commentator on Sky Business.

Latest Articles

Premium

Regenerative medicine: two attractive buys in a fascinating niche

It is a very esoteric niche on the ASX, but regenerative medicine is a fascinating area. ASX-listed companies PolyNovo, AVITA Medical and AROA Biosurgery all focus on regenerative medicine and soft-tissue repair, targeting severe burns, trauma and complex wounds, using active biological or structural reconstruction.

August 17, 2026 · 8 min read
Premium

Two ASX disruptors that could be worth the wait

I went looking for ASX companies that are genuine disruptors trading at attractive prices. I found two global software stars taking on decades-old legacy systems […]

August 10, 2026 · 7 min read
Premium

Two recovering former stars

Two beaten-down stocks are showing signs of life, and in both cases, a hard-fought push into the US market is the reason why.

August 3, 2026 · 8 min read
Premium

Two transformational situations

Here are two situations that have recently been described as "transformational" where I would be prepared to bet on a positive outcome.

July 13, 2026 · 8 min read
Premium

Two copper producing stocks

As the burgeoning demand for AI infrastructure, electrification, the 'energy transition' and defence systems intersects with years of under-investment in mining, many commodities are surging in price and top of the tree is copper. Here are two producers that stand out in terms of value they offer at current share prices.

July 6, 2026 · 8 min read
Premium

Two good value small caps

Here are two small-cap stocks that look to be very good buying at current prices.

July 2, 2026 · 6 min read
Premium

Skin in the game: Two founder-led ASX stars worth backing

I maintain that 'founder-led' companies make up a fascinating little cohort of the ASX and here are two great examples, in very different businesses, that appear to be good buying at current prices.

June 29, 2026 · 7 min read
Premium

Three ASX tungsten stars

Tungsten is one of the most crucial of all of the critical minerals groups but doesn't get much press. Tungsten also plays a growing role in military technologies, AI and the mooted energy transition. The high-tech defence demand for tungsten is really burgeoning. Here's a look at the Australian-listed producers.

June 15, 2026 · 9 min read

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.